GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Deferred Policy Acquisition Costs

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Deferred Policy Acquisition Costs


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Oxford Cannabinoid Technologies Holdings Business Description

Traded in Other Exchanges
N/A
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.